Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYSTEAMINE vs DABRAFENIB\TRAMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYSTEAMINE vs DABRAFENIB\TRAMETINIB: Safety Overview

Metric CYSTEAMINE DABRAFENIB\TRAMETINIB
Total FAERS Reports 1,663 113
Deaths Reported 99 10
Death Rate 6.0% 8.8%
Hospitalizations 484 17
Average Patient Age 20.3 yrs 55.1 yrs
% Female Patients 53.3% 49.5%
FDA Approval Date Apr 30, 2013 N/A
Manufacturer Horizon Therapeutics USA, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A